TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32627803

Group type: EXPERIMENTAL
Intervention: Community health worker support and home blood pressure monitoring
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study: 616279207

Group type: EXPERIMENTAL
Intervention: IFR-guided side-branch intervention group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 50
Study: 35858944

Group type: EXPERIMENTAL
Intervention: Functional alignment (FA) surgical technique
Number of subjects: 240

Group type: COMPARATOR
Intervention: Mechanical alignment (MA) surgical technique (control group)
Number of subjects: 240
Study: 34197676

Group type: EXPERIMENTAL
Intervention: High fruit and vegetable diet
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (usual diet)
Number of subjects: 67
Study: 34625480

Group type: EXPERIMENTAL
Intervention: Singing for Lung Health (SLH) training
Number of subjects: 270

Group type: COMPARATOR
Intervention: Standard physical exercise training (PExT)
Number of subjects: 270
Study: 33941143

Group type: EXPERIMENTAL
Intervention: Passive Glenohumeral Internal Rotation with Clam Shell Bridging
Number of subjects: 42

Group type: COMPARATOR
Intervention: Modified sleeper stretching
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups (Passive Glenohumeral Internal Rotation and Modified sleeper stretching)
Number of subjects: 42
Study: 35691208

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for insomnia (CBTi) - 8 weekly group sessions over 3 months
Number of subjects: 62

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 62
Study: 34417205

Group type: EXPERIMENTAL
Intervention: Remote ischaemic conditioning (RIC) - 4 cycles of blood pressure cuff inflation to 200 mm Hg for 5 min of ischaemia followed by 5 min of reperfusion
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Remote ischaemic conditioning (RIC)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 252
Study: 36306706

Group type: EXPERIMENTAL
Intervention: Modified Atkins diet (MAD)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Levetiracetam
Number of subjects: 101
Study: 33925432

Group type: EXPERIMENTAL
Intervention: Saffron extract (15.5 mg per day)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 66
Study: 32415458

Group type: EXPERIMENTAL
Intervention: Disclosing a history of depression
Number of subjects: 596

Group type: COMPARATOR
Intervention: Disclosing a history of diabetes
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Strong applicants who disclosed depression
Number of subjects: 596
Study: 32638243

Group type: EXPERIMENTAL
Intervention: Primary closure of direct defect prior to mesh placement
Number of subjects: 53

Group type: COMPARATOR
Intervention: Non-closure of direct defect prior to mesh placement
Number of subjects: 53
Study: 35268056

Group type: EXPERIMENTAL
Intervention: Very-Low-Calorie Ketogenic Diet (VLCKD)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Mediterranean Diet (MedDiet)
Number of subjects: 100
Study: 32929501

Group type: EXPERIMENTAL
Intervention: Watchman device implantation
Number of subjects: 5175
Study: 34935229

Group type: EXPERIMENTAL
Intervention: Training and support program tailored to barriers and facilitators for implementing alcohol SBIs (n=6 PHCPs, 110 participants)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Training and support program
Number of subjects: 222

Group type: COMPARATOR
Intervention: Waiting-list control (n=6 PHCPs, 112 participants)
Number of subjects: 222
Study: 32046994

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33185990

Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil (25 mg, 37.5 mg, or 50 mg twice daily)
Number of subjects: 8256

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8256

Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil
Number of subjects: 8256
Study: 32183741

Group type: EXPERIMENTAL
Intervention: Mirabegron (initially 25 mg/day, optional increase to 50 mg/day after week 4/8)
Number of subjects: 887

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 887
Study: 35296780

Group type: EXPERIMENTAL
Intervention: VV116 (oral nucleoside analog)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 32639460

Group type: EXPERIMENTAL
Intervention: V114 Lot 1
Number of subjects: 1051

Group type: EXPERIMENTAL
Intervention: V114 Lot 2
Number of subjects: 1051

Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 1051
Study: 35656740

Group type: EXPERIMENTAL
Intervention: Digital divorce intervention
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Lower neuroticism
Number of subjects: 676
Study: 33737443

Group type: EXPERIMENTAL
Intervention: Epley manoeuvre (EM)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham manoeuvre
Number of subjects: 80
Study: 36418539

Group type: EXPERIMENTAL
Intervention: Support underwear
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no support underwear)
Number of subjects: 50
Study: 34100746

Group type: EXPERIMENTAL
Intervention: Tailor‐made notched music therapy
Number of subjects: 104

Group type: COMPARATOR
Intervention: Ordinary music
Number of subjects: 104
Study: 32029012

Group type: EXPERIMENTAL
Intervention: Twice weekly sessions of CBT or IPT
Number of subjects: 200

Group type: COMPARATOR
Intervention: Weekly sessions of CBT or IPT
Number of subjects: 200
Study: 34905990

Group type: EXPERIMENTAL
Intervention: Health Education and Relationship Training (HEART)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Attention-matched control
Number of subjects: 198
Study: 33581692

Group type: EXPERIMENTAL
Intervention: Serum calcium levels
Number of subjects: 394929

Group type: EXPERIMENTAL
Intervention: Serum selenium levels
Number of subjects: 394929

Group type: EXPERIMENTAL
Intervention: Serum retinol levels
Number of subjects: 394929

Group type: EXPERIMENTAL
Intervention: Vitamin E levels
Number of subjects: 394929

Group type: EXPERIMENTAL
Intervention: Serum retinol and vitamin E levels
Number of subjects: 394929
Study: 33482395

Group type: EXPERIMENTAL
Intervention: Family Automated Voice Reorientation (FAVoR) intervention over a 5-day period
Number of subjects: 178

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: FAVoR intervention
Number of subjects: 178
Study: 34093551

Group type: EXPERIMENTAL
Intervention: Nexvax2 (900 μg, n = 12)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (n = 9)
Number of subjects: 21
Study: 34475136

Group type: EXPERIMENTAL
Intervention: BNT162b2 vaccine
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group (age-matched health care workers)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Both cohorts (patients and controls)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Patient cohort
Number of subjects: 154
Study: 32551868

Group type: EXPERIMENTAL
Intervention: Optimum tension group (96.3 ± 4.9 N)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Maximum tension group (199.0 ± 20.3 N)
Number of subjects: 78
Study: 33502615

Group type: EXPERIMENTAL
Intervention: Digital educational platform (DEP) + Standard verbal consent (SVC)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard verbal consent (SVC)
Number of subjects: 51
Study: 34191140

Group type: EXPERIMENTAL
Intervention: Bacterial cellulose (BC) wound dressing
Number of subjects: 39

Group type: COMPARATOR
Intervention: Cellulose acetate mesh impregnated with essential fatty acids (Rayon®)
Number of subjects: 39
Study: 32011356

Group type: EXPERIMENTAL
Intervention: Advocacy support for family caregivers
Number of subjects: 18

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 18
Study: 616191017

Group type: EXPERIMENTAL
Intervention: Luseogliflozin 2.5 mg once daily for the last 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: HC‐HGI (55% TEC and high GI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: HC‐LGI (55% TEC and low GI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LC‐HGI (40% TEC and high GI)
Number of subjects: 0
Study: 34018672

Group type: EXPERIMENTAL
Intervention: 1-day continuing professional development (CPD) education programme on the International Caries Classification and Management System (ICCMS™) and monthly performance feedback
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 14
Study: 33758968

Group type: EXPERIMENTAL
Intervention: Tele-nursing support
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no tele-nursing support)
Number of subjects: 60
Study: 36093918

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Esketamine (0.25 mg/kg)
Number of subjects: 60
Study: 32369295

Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control
Number of subjects: 72
Study: 32248838

Group type: EXPERIMENTAL
Intervention: Biological nurturing
Number of subjects: 188

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 188
Study: 35977005

Group type: EXPERIMENTAL
Intervention: Brexpiprazole
Number of subjects: 727

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 727
Study: 34392667

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 40
Study: 32126317

Group type: EXPERIMENTAL
Intervention: Supervised group exercise program (twice weekly for 12 weeks)
Number of subjects: 19
Study: 36322381

Group type: EXPERIMENTAL
Intervention: Ortho-phosphoric acid (OPA)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Meta-phosphoric acid (MPA)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Application time of 15 seconds
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Application time of 7 seconds
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Viscosity (gel and liquid)
Number of subjects: 96
Study: 34563112

Group type: EXPERIMENTAL
Intervention: Eye mask (masked group, n=20)
Number of subjects: 38

Group type: COMPARATOR
Intervention: No eye mask (control group, n=18)
Number of subjects: 38
Study: 36031005

Group type: EXPERIMENTAL
Intervention: Memory reactivation under propranolol (25mg)
Number of subjects: 61
Study: 34372670

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (35% fat, 22% monounsaturated fatty acids, <50% carbohydrates)
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Low-fat diet (28% fat, 12% monounsaturated fatty acids, >55% carbohydrates)
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 1002
Study: 32706660

Group type: EXPERIMENTAL
Intervention: Combination of 3D virtual reality and hands-on aromatherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 35633354

Group type: EXPERIMENTAL
Intervention: Cefotaxime (1 g intravenously) given 12 hr. before skin incision (Group 2)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Cefotaxime (1 g intravenously) given 12 hr. after operation (Group 3)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Normal saline given 12 hr. before and after skin incision (Control Group 1)
Number of subjects: 150
Study: 34228855

Group type: EXPERIMENTAL
Intervention: Peg‐interferon alpha add-on with Tenofovir disoproxil fumarate (TDF) for 48 weeks followed by TDF alone for 48 weeks
Number of subjects: 133

Group type: COMPARATOR
Intervention: Tenofovir disoproxil fumarate (TDF) monotherapy for 96 weeks
Number of subjects: 133

Group type: COMPARATOR
Intervention: TDF alone for 48 weeks and sequentially Peg‐IFNα added for 48 weeks
Number of subjects: 133
Study: 32275363

Group type: EXPERIMENTAL
Intervention: Medicinal penetration on acupoint combined with medication (oral prednisone tablets for 40 days, starting with 10 mg three times a day, reducing by 5 mg every 7 days)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Medicinal penetration on acupoint
Number of subjects: 72
Study: 34369837

Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (ALA) 300 mg/day for 8 weeks
Number of subjects: 60
Study: 34910809

Group type: EXPERIMENTAL
Intervention: Combined physical and cognitive training (PTCT)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Physical training (PT)
Number of subjects: 314
Study: 32922107

Group type: EXPERIMENTAL
Intervention: Guided imagery-based smoking cessation intervention (details on dosage and duration not available)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Guided imagery-based smoking cessation intervention
Number of subjects: 51
Study: 34436812

Group type: EXPERIMENTAL
Intervention: Immediate Loading (IL)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Delayed Loading (DL)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 72
Study: 32019981

Group type: EXPERIMENTAL
Intervention: End-effector (EE) robot
Number of subjects: 38

Group type: COMPARATOR
Intervention: Exoskeleton (Exo) robot
Number of subjects: 38
Study: 34157879

Group type: EXPERIMENTAL
Intervention: Small low proliferation cancers (SLPC) in the research series (n=534)
Number of subjects: 8967

Group type: EXPERIMENTAL
Intervention: Small low proliferation cancers (SLPC) in the registry series (n=8433)
Number of subjects: 8967
Study: 34333826

Group type: EXPERIMENTAL
Intervention: High dose (6-fold of MED as initial dose)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Medium dose (4-fold of MED as initial dose)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Low dose (2-fold of MED as initial dose)
Number of subjects: 77
Study: 34808687

Group type: EXPERIMENTAL
Intervention: Teleultrasound
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard in-person ultrasound
Number of subjects: 300
Study: 33233946

Group type: EXPERIMENTAL
Intervention: Positive expiratory pressure blow‐bottle device (G2)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Expiratory positive airway pressure (G3)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional physiotherapy (G1)
Number of subjects: 48
Study: 32561903

Group type: EXPERIMENTAL
Intervention: Weight-loss diet interventions
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: High-protein diet
Number of subjects: 184
Study: 33877376

Group type: EXPERIMENTAL
Intervention: Telemedicine follow-up
Number of subjects: 238

Group type: COMPARATOR
Intervention: Office-based follow-up
Number of subjects: 238
Study: 32969222

Group type: EXPERIMENTAL
Intervention: Block randomization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Complete randomization
Number of subjects: 0
Study: 33333771

Group type: EXPERIMENTAL
Intervention: Oral Rehydration Solution (DD) - carbohydrates: 33 g·L‐1, sodium: 60 ± 3 mmol·L‐1
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Sports Drink (SD) - carbohydrates: 62 g·L‐1, sodium: 31 ± 3 mmol·L‐1
Number of subjects: 9

Group type: COMPARATOR
Intervention: Water (WA)
Number of subjects: 9
Study: 36175936

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate Ringer’s solution (BRS)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Sodium lactate Ringer’s solution
Number of subjects: 400
Study: 33480665

Group type: EXPERIMENTAL
Intervention: Ceftobiprole
Number of subjects: 138

Group type: COMPARATOR
Intervention: Standard-of-care (SoC) cephalosporin
Number of subjects: 138
Study: 33228549

Group type: EXPERIMENTAL
Intervention: Endoscopic screening in high-risk areas
Number of subjects: 149956

Group type: COMPARATOR
Intervention: Endoscopic screening in non-high-risk areas
Number of subjects: 149956
Study: 35458222

Group type: EXPERIMENTAL
Intervention: Zinc-biofortified flour
Number of subjects: 517

Group type: COMPARATOR
Intervention: Control flour
Number of subjects: 517
Study: 33208019

Group type: EXPERIMENTAL
Intervention: Cigarette Smoking (CS)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Electronic Cigarettes (EC)
Number of subjects: 36

Group type: COMPARATOR
Intervention: No Tobacco Product
Number of subjects: 36
Study: 35297463

Group type: EXPERIMENTAL
Intervention: Integrated exercise intervention for 12 months
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group continued daily activities
Number of subjects: 146
Study: 34977248

Group type: EXPERIMENTAL
Intervention: Day 2 discharge after uncomplicated CS
Number of subjects: 228
Study: 34101713

Group type: EXPERIMENTAL
Intervention: Hyperbaric prilocaine 50 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hyperbaric bupivacaine 10 mg
Number of subjects: 40
Study: 33113277

Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg, daily)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sertraline (100 mg, OD)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sertraline (50 mg, OD)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Dapoxetine (30 mg, OD)
Number of subjects: 120
Study: 34898273

Group type: EXPERIMENTAL
Intervention: Atogepant 60 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sumatriptan 100 mg
Number of subjects: 30
Study: 32316009

Group type: EXPERIMENTAL
Intervention: Neural therapy (n = 52)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (no neural therapy, n = 61)
Number of subjects: 113
Study: 35263859

Group type: EXPERIMENTAL
Intervention: Intravenous selenium selenite for 5 days
Number of subjects: 44

Group type: COMPARATOR
Intervention: Normal saline as placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Selenium selenite
Number of subjects: 44
Study: 33539729

Group type: EXPERIMENTAL
Intervention: 24 Gy in 12 fractions
Number of subjects: 548

Group type: COMPARATOR
Intervention: 4 Gy in two fractions
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: Adverse events for 24 Gy
Number of subjects: 548

Group type: COMPARATOR
Intervention: Adverse events for 4 Gy
Number of subjects: 548
Study: 34973513

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg every 3 weeks for ≤2 years
Number of subjects: 340

Group type: COMPARATOR
Intervention: Chemotherapy (investigator's choice of paclitaxel, docetaxel, or irinotecan)
Number of subjects: 340
Study: 34089321

Group type: EXPERIMENTAL
Intervention: Generalized Calibration Modeling (GCM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized Multicomponent Multivariate Modeling (RMMM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined use of GCM and RMMM
Number of subjects: 0
Study: 32524500

Group type: EXPERIMENTAL
Intervention: Denosumab 120 mg subcutaneously
Number of subjects: 196

Group type: COMPARATOR
Intervention: Zoledronic acid 4 mg intravenously every 4 weeks
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 196

Group type: COMPARATOR
Intervention: Zoledronic acid
Number of subjects: 196
Study: 34076068

Group type: EXPERIMENTAL
Intervention: Low-dose ketamine (0.5 mg/kg IV) in addition to propofol anesthesia for ECT
Number of subjects: 45

Group type: COMPARATOR
Intervention: Propofol anesthesia for ECT
Number of subjects: 45
Study: 33788463

Group type: EXPERIMENTAL
Intervention: Thunder-fire moxibustion combined with mifepristone (10 mg once a day) for 3 months
Number of subjects: 70

Group type: COMPARATOR
Intervention: Mifepristone (10 mg once a day) for 3 months
Number of subjects: 70
Study: 36101809

Group type: EXPERIMENTAL
Intervention: Evidence-based nursing intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (standard nursing care)
Number of subjects: 80
Study: 32421612

Group type: EXPERIMENTAL
Intervention: Mindfulness-based compassionate living (MBCL)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 122
Study: 34144908

Group type: EXPERIMENTAL
Intervention: Group self-management education intervention
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Fidelity assessment of the intervention
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Focus group discussions
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Private Facebook group
Number of subjects: 70
Study: 33539573

Group type: EXPERIMENTAL
Intervention: 3D-histology
Number of subjects: 569

Group type: COMPARATOR
Intervention: Serial section histology
Number of subjects: 569
Study: 32188310

Group type: EXPERIMENTAL
Intervention: Telemedicine support in primary care (intervention group, IG)
Number of subjects: 271

Group type: COMPARATOR
Intervention: Standard follow-up in cardiology outpatient clinic (control group, CG)
Number of subjects: 271
Study: 32375572

Group type: EXPERIMENTAL
Intervention: Tribulus Terrestris (TT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 18
Study: 36219978

Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (early‐PN)
Number of subjects: 1247

Group type: COMPARATOR
Intervention: Late parenteral nutrition (late‐PN)
Number of subjects: 1247

Group type: EXPERIMENTAL
Intervention: Early RFH
Number of subjects: 1247

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition intake
Number of subjects: 1247
Study: 33606931

Group type: EXPERIMENTAL
Intervention: Tapentadol (50 mg bid)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Oxycodone (10 mg bid)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 35872874

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.4 μg/(kg·h)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.6 μg/(kg·h)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.8 μg/(kg·h)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.8 μg/(kg·h) in group A3
Number of subjects: 495
Study: 33676882

Group type: EXPERIMENTAL
Intervention: Oral steroids (7-day course) + nasal steroids and douching (12-week course)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Nasal steroids and douching (12-week course)
Number of subjects: 140
Study: 34721571

Group type: EXPERIMENTAL
Intervention: Preconditioning with cathodal HD-tDCS
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham cathodal HD-tDCS preconditioning
Number of subjects: 24
Study: 33187532

Group type: EXPERIMENTAL
Intervention: VR training (45 min, five times per week over 3 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional rehabilitation (45 min, five times per week over 3 weeks)
Number of subjects: 60
Study: 33573598

Group type: EXPERIMENTAL
Intervention: Oxycodone for PCIA + transmuscular quadratus lumborum block
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Oxycodone for PCIA
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sufentanil for PCIA
Number of subjects: 80
Study: 36280159

Group type: EXPERIMENTAL
Intervention: Optimized tourniquet
Number of subjects: 127

Group type: COMPARATOR
Intervention: Without tourniquet
Number of subjects: 127